Tags: FDA
23andMe defends genetic testing product
23andMe Chief Executive Officer Anne Wojcicki defended her company's genetic testing product and stands by the data on the accuracy of their results after the public warning letter issued by the US Food and Drug Administration.
What to watch in the day ahead
Friday is the first day of sales for Sony's PlayStation 4 interactive gaming console. GE holds an meeting for investors and analysts focused on its GE Capital business. The Federal Reserve releases its report on U.S. industrial production.
FDA approves Warner Chilcott’s oral contraceptive LO Minastrin FE
Warner Chilcott has received FDA approval for oral contraceptive LO Minastrin FE. LO Minastrin FE, a chewable oral contraceptive made by Warner Chilcott PLC, has received the stamp of approval from the US Food and Drug Administration.
